Clinical trials
Full profile accessFollow clinical development from study design and recruitment through results.
- Trial phase
- Status
- Readouts
Drug intelligence / Profile preview
fecal microbiota transplant (Duke University)
- Development stage
- Unknown
- Lead developer
- Duke University
- Modality
- Synthetic Biology Platforms → Engineered Microbial Therapeutics → Microbiome Therapeutics, Fresh FMT → Fecal Microbiota Transplantation (FMT) → Microbiome Therapeutics, Yeast Strains → Single Strain Products → Live Biotherapeutic Products → Microbiome Therapeutics, Bacterial Strains → Single Strain Products → Live Biotherapeutic Products → Microbiome Therapeutics, Defined Consortia → Multi-strain Products → Live Biotherapeutic Products → Microbiome Therapeutics, Frozen FMT → Fecal Microbiota Transplantation (FMT) → Microbiome Therapeutics, Genetically Modified Bacteria → Engineered Microbial Therapeutics → Microbiome Therapeutics, Microbial Metabolites → Microbiome-Derived Products → Microbiome Therapeutics, Microbial Proteins → Microbiome-Derived Products → Microbiome Therapeutics, Complex Communities → Multi-strain Products → Live Biotherapeutic Products → Microbiome Therapeutics
- Administration
- Oral
01
Overview
Fecal microbiota transplant is a biologic therapy investigated by Duke University for the treatment of recurrent Clostridioides difficile (formerly Clostridium difficile) infection. The therapy consists of freeze-dried, encapsulated fecal microbiota sourced from healthy, screened donors, which is administered orally. The primary mechanism of action is the restoration of a healthy and diverse gut microbiome. The introduction of beneficial bacteria helps to outcompete and suppress the pathogenic C. difficile, resolving the infection and preventing recurrence. Duke University's Fecal Microbiota Transplantation Program, established in 2019, has been involved in Phase 2 clinical trials to evaluate the safety and efficacy of this encapsulated formulation. [2, 4, 6] While Duke sponsors these investigations, the microbiota preparations have been sourced from external stool banks like OpenBiome. [2, 3]
- Other names
- fecal microbiota-Duke University-Clostridium difficile colitisencapsulated fecal microbiota transplantation
Beyond the preview
Go deeper on fecal microbiota transplant (Duke University).
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Indications & development
Full profile accessExplore development by indication, patient population, and geography.
- Indications
- Development status
- Countries
Licensing & deals
Full profile accessTrace asset ownership, licensing agreements, and commercial partnerships.
- Partners
- Deal terms
- Milestones
Patents & exclusivity
Full profile accessExplore the patent landscape and regulatory exclusivity around an asset.
- Patents
- Expiration dates
- Exclusivity
Competitive landscape
Full profile accessCompare development programs by target, modality, and indication.
- Competing assets
- Targets
- Development stage
Research & analysis
Full profile accessConnect source evidence and development news to your research questions.
- Publications
- News
- Analysis
Bring the full picture into focus.
See how Gosset can support your research on fecal microbiota transplant (Duke University).